Jabra Enhance Plus vs JLab Hear OTC

The Jabra Enhance Plus is a mid-priced OTC hearing aid priced at $799, earning a B grade with a SoundScore of 3.7/5 in our lab testing. This visible-in-ear device ranks #28 of 65 OTC hearing aids tested, placing it in the top 42% of its category. In our testing, the Enhance Plus demonstrated notable strengths in speech clarity and audio streaming. Speech in quiet scored a strong 4.2/5, measuring 1.36 points above the category average. Music streaming performance was equally impressive at 3.8/5, a full 1.88 points above average—making this a solid choice for users who prioritize phone audio streaming. Feedback handling was excellent at 4.7/5. However, the device has a significant weakness: own-voice comfort scored just 0.3/5, falling 2.21 points below the category average. This suggests pronounced occlusion effects that may make the user's own voice sound boomy or unnatural. Speech in noise performance was mixed at 2.1/5—above the category average by 0.62 points, but still limited in absolute terms for challenging listening environments. The Enhance Plus showed meaningful improvement with tuning, jumping from a normalized Initial Score of 3.6/5 to a Tuned Score of 4.2/5. Buyers should note that several competitors in the same price range score higher, including the Sony CRE-E10 at 4.66/5. This device is best suited for users who prioritize music streaming and speech clarity in quieter settings, and who can tolerate own-voice occlusion.

The JLab Hear OTC is a budget-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.5/5 in our lab testing. At $100, it represents one of the most affordable entry points into the OTC hearing aid market, ranking #36 of 65 devices in its category. This visible-in-ear device delivers a distinctive performance profile with clear strengths and weaknesses. Its standout feature is excellent music streaming quality, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect stable performance without whistling during daily activities. These results suggest JLab leveraged its audio expertise from consumer earbuds in developing this product. However, speech clarity presents challenges. Speech in quiet scored 2.1/5 (0.67 points below category average), while speech in noise scored 1.0/5 (0.46 points below average). Own-voice comfort also measured low at 1.8/5. These limitations are significant for users prioritizing conversation clarity, which is typically the primary reason people seek hearing aids. The JLab Hear OTC is best suited for budget-conscious consumers who value music and media streaming alongside basic amplification, rather than those needing maximum speech intelligibility. Features include rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Buyers seeking stronger speech performance in this price range may want to compare options like the higher-scoring Elehear Beyond or Apple AirPods Pro 2.